Business, energy, technology, markets and global industry news from Business News Today

Ozempic

PharmaDeviceNews Ozempic
Pharma & Biotech

Phoenix and Raven launch direct-to-patient generic semaglutide after Health Canada approval

Generic semaglutide is cheaper, but access is now the real battleground. Phoenix and Raven are testing Canada’s GLP-1 telehealth future.

Read More
Representative image: Generic semaglutide injection pens and diabetes-care materials illustrate Apotex’s Health Canada approval for Apo-Semaglutide Injection, a generic Ozempic equivalent that could reshape GLP-1 access and diabetes treatment affordability in Canada.
Pharma & Biotech

Why Apotex’s Apo-Semaglutide approval could reshape Canada’s diabetes drug market

Canada has generic Ozempic momentum. Apotex’s approval turns GLP-1 access into a pricing and supply-chain test.

Read More
Pharma & Biotech

Can Apotex crack the complex generic code for semaglutide before the glucagon-like peptide-1 market resets?

Apotex won first tentative U.S. approval for generic semaglutide. Read what it could mean for glucagon-like peptide-1 access, pricing, and competition.

Read More